www.fdanews.com/articles/69676-medicinova-to-exercise-underwriter-s-over-allotment-option
MediciNova to Exercise Underwriter's Over-Allotment Option
March 9, 2005
MediciNova, a specialty pharmaceutical company that is publicly traded on the Hercules Market of the Osaka Securities Exchange, has announced that the underwriter of its recent initial public offering of 30,000,000 shares of common stock has exercised its over-allotment option to purchase 1,573,000 shares of common stock from MediciNova at a price of 370 Yen per share, net of underwriting discount.
Yahoo News (http://biz.yahoo.com/prnews/050309/law018_1.html)